Transformed microalgae express specific enzymes to generate human-compatible glycan structures, reducing immunogenicity in therapeutic protein production.
Segmented fusion gene assays detect CD74-NRG1 and MTSS1-NRG1 markers to diagnose lung cancer in non-smokers lacking conventional KRAS mutations.
Modified neuregulin peptides target ErbB2 receptors to delay heart failure and cardiac hypertrophy.